Patience and compromise will be key to healing political rifts caused by Medicaid expansion, explained Matt Salo, executive director of the National Association of Medicaid Directors.
Patience and compromise will be key to healing political rifts caused by Medicaid expansion, explained Matt Salo, executive director of the National Association of Medicaid Directors.
Transcript (slightly modified)
We’re seeing more states choosing to expand Medicaid, but what do you think it would take to get all states to expand?
In order to get all states to expand Medicaid, you’re going to need a combination of just time. A lot of the opposition, not all, but a lot of the opposition is political, certainly some is ideological. But if it’s political, then you’re going to need time for some of those political wounds to heal. You know, if you consider the fact that some of the opposition comes from state legislators who have been campaigning their entire elected career against the Affordable Care Act, it’s going to take some time for them to figure out, how are they able to politically pivot and embrace something that they’ve been running against.
So like I said, I think some of that’s just going to take time, but the other piece is going to be, it’s going to take more willingness on the part of the administration, and at this point that’s likely the next administration, to be able to meet those states halfway when it comes to designing different approaches to how do you actually operationalize the expansion.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More